Navidea Biopharmaceuticals Inc (NAVB)
0.0368
-0.01
(-16.36%)
USD |
OTCM |
Apr 23, 16:00
Navidea Biopharmaceuticals Cash from Operations (TTM): -9.714M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -9.714M |
| June 30, 2023 | -1.323M |
| March 31, 2023 | -8.153M |
| December 31, 2022 | -8.987M |
| September 30, 2022 | -9.282M |
| June 30, 2022 | -9.436M |
| March 31, 2022 | -9.712M |
| December 31, 2021 | -10.22M |
| September 30, 2021 | -10.05M |
| June 30, 2021 | -10.67M |
| March 31, 2021 | -10.28M |
| December 31, 2020 | -8.174M |
| September 30, 2020 | -8.350M |
| June 30, 2020 | -8.062M |
| March 31, 2020 | -8.141M |
| December 31, 2019 | -9.355M |
| September 30, 2019 | -8.749M |
| June 30, 2019 | -8.293M |
| March 31, 2019 | 4.37M |
| December 31, 2018 | 4.275M |
| September 30, 2018 | 4.441M |
| June 30, 2018 | 5.381M |
| March 31, 2018 | -10.84M |
| December 31, 2017 | 59.08M |
| September 30, 2017 | 63.30M |
| Date | Value |
|---|---|
| June 30, 2017 | 66.91M |
| March 31, 2017 | 72.90M |
| December 31, 2016 | 3.557M |
| September 30, 2016 | -2.896M |
| June 30, 2016 | -9.641M |
| March 31, 2016 | -16.65M |
| December 31, 2015 | -19.08M |
| September 30, 2015 | -19.71M |
| June 30, 2015 | -22.33M |
| March 31, 2015 | -24.06M |
| December 31, 2014 | -29.13M |
| September 30, 2014 | -35.46M |
| June 30, 2014 | -38.45M |
| March 31, 2014 | -37.39M |
| December 31, 2013 | -35.61M |
| September 30, 2013 | -31.78M |
| June 30, 2013 | -27.13M |
| March 31, 2013 | -24.73M |
| December 31, 2012 | -23.92M |
| September 30, 2012 | -26.32M |
| June 30, 2012 | -24.97M |
| March 31, 2012 | -20.81M |
| December 31, 2011 | -16.01M |
| September 30, 2011 | -7.891M |
| June 30, 2011 | -5.335M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-10.67M
Minimum
Jun 2021
-1.323M
Maximum
Jun 2023
-8.719M
Average
-9.134M
Median
Cash from Operations (TTM) Benchmarks
| Perspective Therapeutics Inc | -36.91M |
| Electromed Inc | 4.872M |
| Xtant Medical Holdings Inc | -9.515M |
| Asensus Surgical Inc | -63.63M |
| Senseonics Holdings Inc | -70.16M |